INS and type 1 diabetes mellitus: While once‐weekly insulin presents a promising option for select T1DM patients, particularly those struggling with daily administration adherence, successful implementation requires careful patient selection, comprehensive monitoring and robust risk mitigation strategies within a framework of shared decision‐making between healthcare providers and patients.